-+ 0.00%
-+ 0.00%
-+ 0.00%

TELITACICEPT RECEIVES NMPA APPROVAL FOR THE TREATMENT OF SJÖGREN’S DISEASE IN CHINA

Reuters·06/08/2026 12:31:00

Please log in to view news